Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I love talking about "Endless Phony Stockhouse ID's"
View:
Post by SouthernTierTom on Feb 05, 2022 2:03pm

I love talking about "Endless Phony Stockhouse ID's"

reminds me of the faux political chit-chat agenda installed when the stock was in the .20 CAD range.

The Vegas Under/Over on actual people posting here is at 4.5 ..I am going "UNDER" ; - )

I love T&A analysis, would this be available on TD Ameritrade too?

My guess is that we have about 3M in cash...when do we "top up"  CV19 has stunted the "spend" for many clinical stage bios...as mentioned below, when we "ramp up" I think we burn more - IMHO ...as mentioned previously you don't roll into Vegas or Besthesda on "fume$"

Only a select few know......

Those fortunate to "BUY" at a time when this very public forum was converted into a "faux political site" are doing VERY well!  Really a $hame the passioante push we are seeing now did not arrive here on the bullboard in the 20 cent zone ; - (

The question is of course are those with 18, 19 or even 22 cent CAD ACBs converting their shares into a nice profit?

You will know in a reasonably short amount of time.

I do not know the company well enough to comment on where the price will go and that is a "mugs game"... I know the TLT bulboard well enough to understand the current message being sent to readers and the amount of willing sellers is not matching the message.

If this is good...and my belief is that it just might be...people will want " more from it " before it leaves the station.  I calculate about 3M in CAD cash at the moment.  Burn rates for most bios are low as clinical activity has been muted during CV19.  Once things ramp up again, money will be needed
Comment by SouthernTierTom on Feb 05, 2022 10:27pm
I must say, a "purchase" in the low 20's would have been prudent..."Monday morning QB's never make it to the Hall of Fame ; - ( I love T&A analysis, would this be available on TD Ameritrade too? My guess is that we have about 3M in cash...when do we "top up"  CV19 has stunted the "spend" for many clinical stage bios...as mentioned below, when ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250